Personal information

Other IDs

Scopus Author ID: 55964554000

Activities

Collapse all

Employment (3)

Peter MacCallum Cancer Centre: Melbourne, VIC, AU

2020 to present | Research Fellow (NCIC)
Employment
Source: Self-asserted source
Julian Lindsay

Fred Hutchinson Cancer Research Center: Seattle, Washington, US

2020 to present | Research Fellow (VIDD)
Employment
Source: Self-asserted source
Julian Lindsay

NSW Health: Sydney, NSW, AU

2013 to 2020 | BMT Pharmacist (Haematology)
Employment
Source: Self-asserted source
Julian Lindsay

Education and qualifications (3)

The University of Melbourne: Melbourne, VIC, AU

PhD (Medicine )
Education
Source: Self-asserted source
Julian Lindsay

Queensland University of Technology: Brisbane, QLD, AU

Bachelor of Pharmacy (Hons)
Education
Source: Self-asserted source
Julian Lindsay

Monash University: Melbourne, Victoria, AU

Masters of Clinical Pharmacy
Education
Source: Self-asserted source
Julian Lindsay

Works (37)

Antibacterial prophylaxis for neutropenic and high-risk hematology patients—Do the benefits outweigh the risk?

Transplant Infectious Disease
2024 | Journal article
DOI: 10.1111/tid.14255
EID:

2-s2.0-85187189106

Part of ISSN: 13993062 13982273
Contributors: Reynolds, G.; Lindsay, J.
Source: Self-asserted source
Julian Lindsay via Scopus - Elsevier

Rituximab for posttransplant lymphoproliferative disorder – therapeutic, preemptive, or prophylactic?

Bone Marrow Transplantation
2024 | Journal article
DOI: 10.1038/s41409-023-02155-5
EID:

2-s2.0-85177688906

Part of ISSN: 14765365 02683369
Contributors: Storek, J.; Lindsay, J.
Source: Self-asserted source
Julian Lindsay via Scopus - Elsevier

Antimicrobials in patients with hematologic malignancies and recipients of hematopoietic cell transplantation and other cellular therapies

Transplant Infectious Disease
2023 | Journal article
DOI: 10.1111/tid.14129
EID:

2-s2.0-85168360371

Part of ISSN: 13993062 13982273
Contributors: Tverdek, F.; Escobar, Z.K.; Liu, C.; Jain, R.; Lindsay, J.
Source: Self-asserted source
Julian Lindsay via Scopus - Elsevier

Expanding the scope of the infectious diseases pharmacist in HCT: Beyond antimicrobial stewardship

Transplant Infectious Disease
2023 | Journal article
DOI: 10.1111/tid.14094
EID:

2-s2.0-85164461713

Part of ISSN: 13993062 13982273
Contributors: Weerdenburg, H.; Lindsay, J.
Source: Self-asserted source
Julian Lindsay via Scopus - Elsevier

Invasive fungal infections after CLAG-M/CLAG chemotherapy for acute myeloid leukemia and high-grade myeloid neoplasms

Blood Advances
2023 | Journal article
DOI: 10.1182/bloodadvances.2022009562
EID:

2-s2.0-85169667138

Part of ISSN: 24739537 24739529
Contributors: Lindsay, J.; Walti, C.S.; Halpern, A.B.; Xie, H.; Chung, E.L.; Schonhoff, K.G.; Huebner, E.M.; Cheng, G.-S.; Kimball, L.E.; Leisenring, W.M. et al.
Source: Self-asserted source
Julian Lindsay via Scopus - Elsevier

Subtherapeutic concentrations of posaconazole tablet: determining risk factors and effectiveness of a standardized dose adjustment in hematology inpatients

Leukemia and Lymphoma
2022 | Journal article
DOI: 10.1080/10428194.2022.2126282
EID:

2-s2.0-85139175476

Part of ISSN: 10292403 10428194
Contributors: Bui, J.; Gellatly, R.; Othman, J.; Lindsay, J.
Source: Self-asserted source
Julian Lindsay via Scopus - Elsevier

Treatment failure cost analysis of Cytomegalovirus (CMV) management in allogeneic hematopoietic cell transplantation

Leukemia and Lymphoma
2022 | Journal article
DOI: 10.1080/10428194.2022.2064992
EID:

2-s2.0-85129241882

Part of ISSN: 10292403 10428194
Contributors: Lindsay, J.; Greenwood, M.; Othman, J.; Chen, S.C.-A.; Kong, D.C.M.; Pergam, S.A.; Liu, C.; Slavin, M.A.
Source: Self-asserted source
Julian Lindsay via Scopus - Elsevier

Voriconazole in Hematopoietic Stem Cell Transplantation and Cellular Therapies: Real-World Usage and Therapeutic Level Attainment at a Major Transplantation Center

Transplantation and Cellular Therapy
2022 | Journal article
DOI: 10.1016/j.jtct.2022.05.030
EID:

2-s2.0-85133261050

Part of ISSN: 26666367
Contributors: Lindsay, J.; Krantz, E.M.; Morris, J.; Sweet, A.; Tverdek, F.; Joshi, A.; Yeh, R.; Hill, J.A.; Greenwood, M.; Chen, S.C.-A. et al.
Source: Self-asserted source
Julian Lindsay via Scopus - Elsevier

Choice and duration of antifungal prophylaxis and treatment in high-risk haematology patients

Current opinion in infectious diseases
2021 | Journal article
DOI: 10.1097/QCO.0000000000000737
EID:

2-s2.0-85112119433

Part of ISSN: 14736527
Contributors: Coussement, J.; Lindsay, J.; Teh, B.W.; Slavin, M.
Source: Self-asserted source
Julian Lindsay via Scopus - Elsevier

Consensus guidelines for antifungal prophylaxis in haematological malignancy and haemopoietic stem cell transplantation, 2021

Internal Medicine Journal
2021 | Journal article
DOI: 10.1111/imj.15588
EID:

2-s2.0-85111935854

Part of ISSN: 14455994 14440903
Contributors: Teh, B.W.; Yeoh, D.K.; Haeusler, G.M.; Yannakou, C.K.; Fleming, S.; Lindsay, J.; Slavin, M.A.; Chang, C.C.; Blyth, C.C.; Chen, S.C.-A. et al.
Source: Self-asserted source
Julian Lindsay via Scopus - Elsevier

Cytomegalovirus (CMV) management in allogeneic hematopoietic cell transplantation: Pre-transplant predictors of survival, reactivation, and spontaneous clearance

Transplant Infectious Disease
2021 | Journal article
DOI: 10.1111/tid.13548
EID:

2-s2.0-85099063751

Part of ISSN: 13993062 13982273
Contributors: Lindsay, J.; Othman, J.; Kerridge, I.; Fay, K.; Stevenson, W.; Arthur, C.; Chen, S.C.A.; Kong, D.C.M.; Pergam, S.A.; Liu, C. et al.
Source: Self-asserted source
Julian Lindsay via Scopus - Elsevier

Dynamics of Epstein–Barr virus on post-transplant lymphoproliferative disorders after antithymocyte globulin-conditioned allogeneic hematopoietic cell transplant

Transplant Infectious Disease
2021 | Journal article
DOI: 10.1111/tid.13719
EID:

2-s2.0-85114674503

Part of ISSN: 13993062 13982273
Contributors: Lindsay, J.; Othman, J.; Yong, M.K.; Ritchie, D.; Chee, L.; Tay, K.; Tio, S.Y.; Kerridge, I.; Fay, K.; Stevenson, W. et al.
Source: Self-asserted source
Julian Lindsay via Scopus - Elsevier

Epstein-Barr virus posttransplant lymphoproliferative disorder: update on management and outcomes

Current opinion in infectious diseases
2021 | Journal article
DOI: 10.1097/QCO.0000000000000787
EID:

2-s2.0-85120053201

Part of ISSN: 14736527
Contributors: Lindsay, J.; Othman, J.; Heldman, M.R.; Slavin, M.A.
Source: Self-asserted source
Julian Lindsay via Scopus - Elsevier

Infection-Related Mortality in Adults and Children Undergoing Allogeneic Hematopoietic Cell Transplantation: An Australian Registry Report

Transplantation and Cellular Therapy
2021 | Journal article
DOI: 10.1016/j.jtct.2021.05.028
EID:

2-s2.0-85109457399

Part of ISSN: 26666367
Contributors: Lindsay, J.; Kerridge, I.; Wilcox, L.; Tran, S.; O'Brien, T.A.; Greenwood, M.; Chen, S.C.-A.; Kong, D.C.M.; Pergam, S.A.; Liu, C. et al.
Source: Self-asserted source
Julian Lindsay via Scopus - Elsevier

SUBA-Itraconazole for Primary Antifungal Prophylaxis After Allogeneic Hematopoietic Cell Transplantation

Open Forum Infectious Diseases
2021 | Journal article
DOI: 10.1093/ofid/ofab502
EID:

2-s2.0-85133279863

Part of ISSN: 23288957
Contributors: Lindsay, J.; Othman, J.; Kong, Y.; Yip, A.; Van Hal, S.; Larsen, S.; Bryant, C.; Gibson, J.; Kerridge, I.; Fay, K. et al.
Source: Self-asserted source
Julian Lindsay via Scopus - Elsevier

Pralatrexate in relapsed/refractory T-cell lymphoma: a retrospective multicenter study.

Leukemia & lymphoma
2020-10-07 | Journal article
DOI: 10.1080/10428194.2020.1827241
LENSID: 089-153-494-693-51X
PMID: 33026266
Contributors: Mansi Bhurani; Lorenz Admojo; Carrie van der Weyden; Robert Twigger; Ali Bazargan; HANG QUACH; Allan Zimet; Luke Coyle; Julian Lindsay; Dejan Radeski et al.
Source: Self-asserted source
Julian Lindsay via The Lens
grade
Preferred source (of 2)‎

Pharmacist review of high-risk haematology outpatients to improve appropriateness of antifungal prophylaxis.

International journal of clinical pharmacy
2020-10-03 | Journal article
DOI: 10.1007/s11096-020-01090-5
LENSID: 007-321-063-093-489
PMID: 33009604
Contributors: Zainab Reslan; Julian Lindsay; Ian Kerridge; Rochelle Gellatly
Source: Self-asserted source
Julian Lindsay via The Lens
grade
Preferred source (of 2)‎

Epstein-Barr virus related post-transplant lymphoproliferative disorder prevention strategies in allogeneic hematopoietic stem cell transplantation.

Reviews in medical virology
2020-04-17 | Journal article | Author
DOI: 10.1002/rmv.2108
LENSID: 009-524-296-504-608
PMID: 32301566
Contributors: Julian Lindsay; Michelle Yong; Matthew Greenwood; David C. M. Kong; Sharon C.-A. Chen; Prof William Rawlinson; Monica A. Slavin
Source: Self-asserted source
Julian Lindsay via The Lens
grade
Preferred source (of 2)‎

Predictors of CMV Reactivation and Survival in Adult Allogeneic HSCT Recipients without CMV Prophylaxis

Biology of Blood and Marrow Transplantation
2020-03 | Journal article
DOI: 10.1016/j.bbmt.2019.12.341
LENSID: 142-166-586-471-669
Contributors: Julian Lindsay; Matthew Greenwood; Jad Othman; Sharon C.-A. Chen; David C. M. Kong; Monica A. Slavin
Source: Self-asserted source
Julian Lindsay via The Lens

New advances in the management of cytomegalovirus in allogeneic haemopoietic stem cell transplantation.

Internal medicine journal
2020-03-05 | Journal article
DOI: 10.1111/imj.14462
LENSID: 113-533-842-470-05X
PMID: 31403736
Contributors: Michelle Yong; David Gottlieb; Julian Lindsay; Jen Kok; William D. Rawlinson; Monica A. Slavin; David Ritchie; Ashish Bajel; Andrew Grigg
Source: Self-asserted source
Julian Lindsay via The Lens
grade
Preferred source (of 2)‎

Azole antifungals and new targeted therapies for hematological malignancy.

Current opinion in infectious diseases
2019-12 | Journal article
DOI: 10.1097/qco.0000000000000611
LENSID: 056-753-794-305-971
PMID: 31688198
Contributors: Julian Lindsay; Benjamin Teh; Kenneth P. Micklethwaite; Monica A. Slavin
Source: Self-asserted source
Julian Lindsay via The Lens
grade
Preferred source (of 2)‎

Oral fludarabine is an effective and convenient alternative to intravenous fludarabine in fludarabine melphalan based reduced intensity conditioning regimens.

Bone marrow transplantation
2019-10-07 | Journal article
DOI: 10.1038/s41409-019-0713-z
LENSID: 129-734-402-509-434
PMID: 31591449
Contributors: Yadanar Lwin; Julian Lindsay; C. Reid; Kelly Wong; Ian Kerridge; Christopher Arthur; Keith Fay; William Stevenson; Matt Greenwood
Source: Self-asserted source
Julian Lindsay via The Lens
grade
Preferred source (of 2)‎

Adherence to Antifungal Guidelines in Malignant Hematology Patients: A Review of the Literature:

Journal of Pharmacy Technology
2019-07-07 | Journal article
DOI: 10.1177/8755122519859976
LENSID: 007-843-572-973-36X
Contributors: Zainab Reslan; Julian Lindsay; Ian Kerridge; Rochelle Gellatly
Source: Self-asserted source
Julian Lindsay via The Lens
grade
Preferred source (of 2)‎

1139. Novel Formulation SUBA-Itraconazole Prophylaxis in Patients With Hematological Malignancy or Undergoing Allogeneic Stem Cell Transplantation: Follow-up Survival Data

Open Forum Infectious Diseases
2018-11-26 | Journal article
DOI: 10.1093/ofid/ofy210.972
LENSID: 130-103-616-961-295
Contributors: Julian Lindsay; Indy Sandaradura; Kelly Wong; Christopher Arthur; William Stevenson; Ian Kerridge; Keith Fay; Luke Coyle; Matthew Greenwood
Source: Self-asserted source
Julian Lindsay via The Lens

1354. Novel Formulation SUBA-Itraconazole in Fed and Fasted Healthy Volunteers: Expanding the Clinical Utility of the Established Mold Active Agent

Open Forum Infectious Diseases
2018-11-26 | Journal article
DOI: 10.1093/ofid/ofy210.1185
LENSID: 056-942-342-548-625
Contributors: Julian Lindsay; Stuart Mudge
Source: Self-asserted source
Julian Lindsay via The Lens

Effects of Food and Omeprazole on a Novel Formulation of Super Bioavailability Itraconazole in Healthy Subjects.

Antimicrobial agents and chemotherapy
2018-10-08 | Journal article | Author
DOI: 10.1128/aac.01723-18
LENSID: 003-479-258-352-289
PMC: 6256753
PMID: 30297369
Contributors: Julian Lindsay; Stuart Mudge; George Richard Thompson
Source: Self-asserted source
Julian Lindsay via The Lens
grade
Preferred source (of 2)‎

New Formulation Suba-Itraconazole Prophylaxis in Patients with Haematological Malignancy or Undergoing Allogeneic Stem Cell Transplantation

Biology of Blood and Marrow Transplantation
2018-03 | Journal article
DOI: 10.1016/j.bbmt.2017.12.282
LENSID: 122-613-372-341-662
Contributors: Julian Lindsay; Indy Sandaradura; Kelly Wong; Christopher Arthur; William Stevenson; Ian Kerridge; Keith Fay; Luke Coyle; Matthew Greenwood
Source: Self-asserted source
Julian Lindsay via The Lens

Serum levels, safety and tolerability of new formulation SUBA-itraconazole prophylaxis in patients with haematological malignancy or undergoing allogeneic stem cell transplantation.

The Journal of antimicrobial chemotherapy
2017-09-11 | Journal article | Author
DOI: 10.1093/jac/dkx295
LENSID: 008-259-319-788-826
PMID: 28961894
Contributors: Julian Lindsay; Indy Sandaradura; Kelly Wong; Christopher Arthur; William Stevenson; Ian Kerridge; Keith Fay; Luke Coyle; Matthew Greenwood
Source: Self-asserted source
Julian Lindsay via The Lens
grade
Preferred source (of 2)‎

Defibrotide Use in Vincristine-induced Hepatic Sinusoidal Obstruction Syndrome.

Clinical lymphoma, myeloma & leukemia
2017-06-30 | Journal article
DOI: 10.1016/j.clml.2017.06.032
LENSID: 078-596-106-254-114
PMID: 28842141
Contributors: Catherine Tang; Julian Lindsay; Anthony J. Gill; Ian Kerridge
Source: Self-asserted source
Julian Lindsay via The Lens
grade
Preferred source (of 2)‎

Epidemiology of complementary and alternative medicine therapy use in allogeneic hematopoietic stem cell transplant survivorship patients in Australia.

Cancer medicine
2016-10-27 | Journal article | Author
DOI: 10.1002/cam4.889
LENSID: 110-558-891-326-806
PMID: 27790858
PMC: 5224858
Contributors: Julian Lindsay; Masrura Kabir; Nicole Gilroy; Gemma Dyer; Lisa Brice; John Moore; Matthew Greenwood; Mark P. Hertzberg; David Gottlieb; Stephen Larsen et al.
Source: Self-asserted source
Julian Lindsay via The Lens
grade
Preferred source (of 2)‎

Safety, clinical effectiveness and trough plasma concentrations of intravenous posaconazole in patients with haematological malignancies and/or undergoing allogeneic haematopoietic stem cell transplantation: off-trial experience.

The Journal of antimicrobial chemotherapy
2016-08-11 | Journal article
DOI: 10.1093/jac/dkw322
LENSID: 108-782-251-044-135
PMID: 27521358
Contributors: Wirawan Jeong; Peter Haywood; Naranie Shanmuganathan; Julian Lindsay; Karen Urbancic; Michelle Ananda-Rajah; Sharon C.-A. Chen; Ashish Bajel; David Ritchie; Andrew Grigg et al.
Source: Self-asserted source
Julian Lindsay via The Lens
grade
Preferred source (of 2)‎

Complementary and Alternative Medicine Therapy (CAM) Use by Allogeneic BMT Survivorship Patients

Biology of Blood and Marrow Transplantation
2016-03 | Journal article
DOI: 10.1016/j.bbmt.2015.11.1091
LENSID: 003-607-608-631-944
Contributors: Julian Lindsay; Masrura Kabir; Nicky Gilroy; Gemma Dyer; Lisa Brice; Matthew Greenwood; John Moore; Mark Hertzberg; Stephen Larsen; John Kwan et al.
Source: Self-asserted source
Julian Lindsay via The Lens

Posaconazole Plasma Concentrations during Intravenous to Oral Tablet Crossover: Are Variations Due to Distribution and Metabolism Rather Than Absorption?

Biology of Blood and Marrow Transplantation
2016-03 | Journal article
DOI: 10.1016/j.bbmt.2015.11.1090
LENSID: 113-501-347-682-980
Contributors: Julian Lindsay; Karim Ibrahim; Indy Sandaradura
Source: Self-asserted source
Julian Lindsay via The Lens

The development and evaluation of an oncological palliative care deprescribing guideline: the ‘OncPal deprescribing guideline’

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
2014-07-01 | Journal article
DOI: 10.1007/s00520-014-2322-0
LENSID: 028-872-495-750-852
PMID: 24975044
Contributors: Julian Lindsay; Michael J. Dooley; Jennifer Martin; Michael Fay; Alison Mary Kearney; Mohsina Khatun; Michael Barras
Source: Self-asserted source
Julian Lindsay via The Lens
grade
Preferred source (of 2)‎

Facing the challenges of new melanoma-targeted therapies: Treatment of severe fevers associated with dabrafenib/trametinib combination therapy

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
2014-03-24 | Journal article
DOI: 10.1177/1078155214527859
LENSID: 044-433-968-666-163
PMID: 24664475
Contributors: Julian Lindsay; Michael Barras
Source: Self-asserted source
Julian Lindsay via The Lens
grade
Preferred source (of 2)‎

Reducing potentially inappropriate medications in palliative cancer patients: evidence to support deprescribing approaches

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
2013-12-21 | Journal article
DOI: 10.1007/s00520-013-2098-7
LENSID: 006-471-693-979-548
PMID: 24362845
Contributors: Julian Lindsay; Michael J. Dooley; Jennifer Martin; Michael Fay; Alison Mary Kearney; Michael Barras
Source: Self-asserted source
Julian Lindsay via The Lens
grade
Preferred source (of 2)‎

Structure, Function and Polymorphism of Human Cytosolic Sulfotransferases

Current drug metabolism
2008-02-01 | Journal article
DOI: 10.2174/138920008783571819
LENSID: 007-683-110-536-448
PMID: 18288952
Contributors: Julian Lindsay; Linlin Wang; Yong Li; Shu-Feng Zhou
Source: Self-asserted source
Julian Lindsay via The Lens
grade
Preferred source (of 2)‎

Peer review (10 reviews for 6 publications/grants)

Review activity for BMC cancer (1)
Review activity for Bone marrow transplantation (1)
Review activity for Clinical infectious diseases : (4)
Review activity for Leukemia (1)
Review activity for Open forum infectious diseases. (2)
Review activity for PloS one. (1)
How many people are using ORCID?